Quoin Pharmaceuticals, Ltd. (QNRX)
Automate Your Wheel Strategy on QNRX
With Tiblio's Option Bot, you can configure your own wheel strategy including QNRX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol QNRX
- Rev/Share 0.0
- Book/Share 10.1066
- PB 0.8974
- Debt/Equity 0.0
- CurrentRatio 2.5737
- ROIC -0.8743
- MktCap 5334666.0
- FreeCF/Share -15.3753
- PFCF -0.5918
- PE -0.5094
- Debt/Assets 0.0
- DivYield 0
- ROE -0.0045
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
ASHBURN, Va., April 30, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases, today announces that it has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Read More
About Quoin Pharmaceuticals, Ltd. (QNRX)
- IPO Date 2016-08-01
- Website https://quoinpharma.com
- Industry Biotechnology
- CEO Dr. Michael Myers Ph.D.
- Employees 3